Registered entities
Lifemine Therapeutics, Inc.
Reg. No. 5037317United States
Lifemine Therapeutics, Inc.
Reg. No. 813783202United States
LIFEMINE THERAPEUTICS, INC.
Reg. No. 81-3783202Belgium
Innovation
9 patent families (1 granted) — focus: Physics & computing, Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 338 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 1 |
Social engagement
Social engagement: 12.9K social following, 2 posts in the last 12 months — around the industry typical range.
Investor mix
14 investors on record; lead investors include Array, Milky Way Cap, 6 Dimensions Capital, Fidelity Investments.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 50% |
| Private equity | 3 | 21% |
| Other / undisclosed | 4 | 29% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
24 Jun 2024 · Senior Director, Data Science · Cambridge
Based on job postings tracked across public sources.
Recent activity
27 Apr 2026
Leadership hire
VP, Clinical Development